Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
92.39
-1.56 (-1.66%)
Jan 29, 2026, 5:09 PM GMT
-9.09%
Market Cap100.98B
Revenue (ttm)14.39B +21.6%
Net Income2.08B +55.7%
EPS1.39 +54.7%
Shares Outn/a
PE Ratio48.64
Forward PE28.07
Dividendn/a
Ex-Dividend Daten/a
Volume25,075
Average Volume9,404
Open93.34
Previous Close93.95
Day's Range92.25 - 94.99
52-Week Range84.86 - 109.51
Beta0.67
RSI48.73
Earnings DateFeb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 53,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

A Closer Look at Boston Scientific's Options Market Dynamics

Financial giants have made a conspicuous bullish move on Boston Scientific. Our analysis of options history for Boston Scientific (NYSE: BSX) revealed 21 unusual trades. Delving into the details, we ...

6 days ago - Benzinga

Weaver Capital Management LLC Sells 119 Shares of Boston Scientific Corp (BSX)

Weaver Capital Management LLC Sells 119 Shares of Boston Scientific Corp (BSX)

7 days ago - GuruFocus

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

In Q4 2025, Polen Capital initiated a new position in Tencent Holdings and Spotify and sold its positions in Sage Group, Willis Towers Watson, ICON Plc, and Workday. Eli Lilly was the top performing r...

7 days ago - Seeking Alpha

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery s...

8 days ago - Benzinga

J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll

Johnson & Johnson stock fell Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.

8 days ago - Investor's Business Daily

Independence Bank of Kentucky Buys 1,007 Shares of Boston Scientific Corp (BSX)

Independence Bank of Kentucky Buys 1,007 Shares of Boston Scientific Corp (BSX)

8 days ago - GuruFocus

GraniteShares Advisors LLC Sells 12,112 Shares of Boston Scientific Corp (BSX)

GraniteShares Advisors LLC Sells 12,112 Shares of Boston Scientific Corp (BSX)

8 days ago - GuruFocus

Revolve Wealth Partners, LLC Sells 2,126 Shares of Boston Scientific Corp (BSX)

Revolve Wealth Partners, LLC Sells 2,126 Shares of Boston Scientific Corp (BSX)

8 days ago - GuruFocus

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 4.48% on an annualized basis producing an average annual return of 18.03%. Currently, Boston Scientific has a marke...

8 days ago - Benzinga

HARBOR CAPITAL ADVISORS, INC. Sells 31 Shares of Boston Scientific Corp (BSX)

HARBOR CAPITAL ADVISORS, INC. Sells 31 Shares of Boston Scientific Corp (BSX)

8 days ago - GuruFocus

TOTH FINANCIAL ADVISORY CORP Buys 67 Shares of Boston Scientific Corp (BSX)

TOTH FINANCIAL ADVISORY CORP Buys 67 Shares of Boston Scientific Corp (BSX)

9 days ago - GuruFocus

Marquette Asset Management, LLC Sells 204 Shares of Boston Scientific Corp (BSX)

Marquette Asset Management, LLC Sells 204 Shares of Boston Scientific Corp (BSX)

9 days ago - GuruFocus

MRA Advisory Group Sells 2,547 Shares of Boston Scientific Corp (BSX)

MRA Advisory Group Sells 2,547 Shares of Boston Scientific Corp (BSX)

9 days ago - GuruFocus

Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus

Wall Street healthcare weekly recap: UNH Medicare probe, Lilly-Nvidia AI drug lab, BSX-Penumbra deal, AbbVie pricing pact, plus top XLV movers—read now.

11 days ago - Seeking Alpha

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

NEW YORK and NEW ORLEANS, Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

12 days ago - PRNewsWire

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Boston Scientific (BSX) shares have decreased by 8.5% over the past 5 trading days. This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra acqui...

13 days ago - Forbes

Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround

Boston Scientific (BSX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es...

13 days ago - Nasdaq

Boston Scientific (BSX): Oppenheimer Adjusts Price Target, Maintains Rating | BSX Stock News

Boston Scientific (BSX): Oppenheimer Adjusts Price Target, Maintains Rating | BSX Stock News

13 days ago - GuruFocus

Boston Scientific's Bet On Penumbra Isn't To My Liking

Boston Scientific will acquire Penumbra for $14.5B in cash, gaining thrombectomy exposure while adding $10.7B in net debt. Learn more on BSX and PEN stocks here.

13 days ago - Seeking Alpha

Boston Scientific's $14.5B Acquisition of Penumbra Raises Investor Concerns

Boston Scientific's $14.5B Acquisition of Penumbra Raises Investor Concerns

14 days ago - GuruFocus